Forced Expression of Alpha-myosin Heavy Chain in the Rabbit Ventricle Results in Cardioprotection Under Cardiomyopathic Conditions

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2005 May 4

PMID 15867177

Citations 35

Authors

Jeanne James

Lisa Martin

Maike Krenz

Carmen Quatman

Fred Jones

Raisa Klevitsky

James Gulick

Jeffrey Robbins

Affiliations

Soon will be listed here.

Abstract

Background: The biochemical differences between the 2 mammalian cardiac myosin heavy chains (MHCs), alpha-MHC and beta-MHC, are well described, but the physiological consequences of basal isoform expression and isoform shifts in response to altered cardiac load are not clearly understood. Mature human ventricle contains primarily the beta-MHC isoform. However, the alpha-MHC isoform can be detected in healthy human ventricle and appears to be significantly downregulated in failing hearts. The unique biochemical properties of the alpha-MHC isoform might offer functional advantages in a failing heart that is expressing only the beta-MHC isoform. This hypothesis cannot be tested in mice or rats because both species express alpha-MHC as the predominant isoform.

Methods And Results: To test the effects of persistent alpha-MHC expression on the background of beta-MHC, we made transgenic (TG) rabbits that expressed rabbit alpha-MHC cDNA in the ventricle so that the endogenous myosin was partially replaced by the transgenically encoded species. Molecular, histological, and functional analyses showed no significant baseline effects in the TG rabbits compared with nontransgenic (NTG) littermates. To determine whether alpha-MHC expression afforded any advantages to stressed myocardium, a cohort of TG and NTG rabbits was subjected to rapid ventricular pacing. Although both the TG and NTG rabbits developed dilated cardiomyopathy, the TG rabbits had a higher shortening fraction, less septal thinning, and more normal +/-dP/dt than paced NTG rabbits.

Conclusions: Transgenic expression of alpha-MHC does not have any apparent detrimental effects under basal conditions and is cardioprotective in experimental tachycardia-induced cardiomyopathy.

Citing Articles

The Pathobiology of Myocardial Recovery and Remission: From Animal Models to Clinical Observations in Heart Failure Patients.

Park A, Mann D Methodist Debakey Cardiovasc J. 2024; 20(4):16-30.

PMID: 39184167 PMC: 11342835. DOI: 10.14797/mdcvj.1389.

Hypertrophic cardiomyopathy in carriers in aging.

Ananthamohan K, Stelzer J, Sadayappan S J Cardiovasc Aging. 2024; 4(1.

PMID: 38406555 PMC: 10883298. DOI: 10.20517/jca.2023.29.

Cardiac ventricular myosin and slow skeletal myosin exhibit dissimilar chemomechanical properties despite bearing the same myosin heavy chain isoform.

Wang T, Spahiu E, Osten J, Behrens F, Grunhagen F, Scholz T J Biol Chem. 2022; 298(7):102070.

PMID: 35623390 PMC: 9243179. DOI: 10.1016/j.jbc.2022.102070.

Lipids: a Potential Molecular Pathway Towards Diastolic Dysfunction in Youth-Onset Type 2 Diabetes.

Shah A, Sadayappan S, Urbina E Curr Atheroscler Rep. 2022; 24(2):109-117.

PMID: 35080716 PMC: 8930525. DOI: 10.1007/s11883-022-00989-w.

Genetic insight into sick sinus syndrome.

Thorolfsdottir R, Sveinbjornsson G, Aegisdottir H, Benonisdottir S, Stefansdottir L, Ivarsdottir E Eur Heart J. 2021; 42(20):1959-1971.

PMID: 33580673 PMC: 8140484. DOI: 10.1093/eurheartj/ehaa1108.

References

Lowes B, Minobe W, Abraham W, Rizeq M, Bohlmeyer T, QUAIFE R . Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997; 100(9):2315-24. PMC: 508428. DOI: 10.1172/JCI119770. View

Gulick J, Hewett T, Klevitsky R, Buck S, Moss R, Robbins J . Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997; 80(5):655-64. DOI: 10.1161/01.res.80.5.655. View

Sugiura S, Kobayakawa N, Fujita H, Yamashita H, Momomura S, Chaen S . Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ Res. 1998; 82(10):1029-34. DOI: 10.1161/01.res.82.10.1029. View

Sugiura S, Kobayakawa N, Fujita H, Momomura S, Chaen S, Sugi H . Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv Exp Med Biol. 1999; 453:125-30. DOI: 10.1007/978-1-4684-6039-1_15. View

James J, Osinska H, Hewett T, Kimball T, Klevitsky R, Witt S . Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology. Transgenic Res. 1999; 8(1):9-22. DOI: 10.1023/a:1008894507995. View

Nakao K, Minobe W, Roden R, Bristow M, Leinwand L . Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997; 100(9):2362-70. PMC: 508434. DOI: 10.1172/JCI119776. View

Tardiff J, Hewett T, Factor S, Vikstrom K, Robbins J, Leinwand L . Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol. 2000; 278(2):H412-9. DOI: 10.1152/ajpheart.2000.278.2.H412. View

Miyata S, Minobe W, Bristow M, Leinwand L . Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res. 2000; 86(4):386-90. DOI: 10.1161/01.res.86.4.386. View

James J, Sanbe A, Yager K, Martin L, Klevitsky R, Robbins J . Genetic manipulation of the rabbit heart via transgenesis. Circulation. 2000; 101(14):1715-21. DOI: 10.1161/01.cir.101.14.1715. View

10.

Tyska M, Hayes E, Giewat M, Seidman C, Seidman J, Warshaw D . Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res. 2000; 86(7):737-44. DOI: 10.1161/01.res.86.7.737. View

11.

Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X . In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000; 87(4):296-302. DOI: 10.1161/01.res.87.4.296. View

12.

James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett T . Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000; 87(9):805-11. DOI: 10.1161/01.res.87.9.805. View

13.

Reiser P, Portman M, Ning X, Schomisch Moravec C . Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol. 2001; 280(4):H1814-20. DOI: 10.1152/ajpheart.2001.280.4.H1814. View

14.

Luchner A, Muders F, Dietl O, Friedrich E, Blumberg F, Protter A . Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res. 2001; 51(3):601-7. DOI: 10.1016/s0008-6363(01)00316-9. View

15.

Tibayan F, Lai D, Timek T, Dagum P, Liang D, Daughters G . Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2002; 124(1):43-9. DOI: 10.1067/mtc.2002.121299. View

16.

James J, Zhang Y, Wright K, Witt S, Glascock E, Osinska H . Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2002; 34(7):873-82. DOI: 10.1006/jmcc.2002.2025. View

17.

Wu Y, Bell S, Trombitas K, Witt C, Labeit S, LeWinter M . Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation. 2002; 106(11):1384-9. DOI: 10.1161/01.cir.0000029804.61510.02. View

18.

Abraham W, Gilbert E, Lowes B, Minobe W, Larrabee P, Roden R . Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med. 2003; 8(11):750-60. PMC: 2039952. View

19.

Parsons S, Millay D, Wilkins B, Bueno O, Tsika G, Neilson J . Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem. 2004; 279(25):26192-200. DOI: 10.1074/jbc.M313800200. View

20.

Pardee J, Spudich J . Purification of muscle actin. Methods Cell Biol. 1982; 24:271-89. DOI: 10.1016/s0091-679x(08)60661-5. View